Search
Now showing items 1-10 of 26
Venous thromboembolism increases the risk of atrial fibrillation: The tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-06-05)
Albuminuria is a well known risk factor for cardiovascular disease and mortality, but focus on renal tubular dysfunction as a potential risk factor is growing also. The association between the urinary activity of N-acetyl-β-D-glucosaminidase (NAG) and cardiovascular risk has been assessed mostly in cross-sectional studies. We studied the cross-sectional associations between urinary NAG and cardiovascular ...
Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2012)
Low serum 25(OH)D levels are associated with cardiovascular risk factors, and also predict future myocardial infarction (MI), type 2 diabetes (T2DM), cancer and all-cause mortality. Recently several single nucleotide polymorphisms (SNPs) associated with serum 25-hydroxyvitamin D (25(OH)D) level have been identified. If these relations are causal one would expect a similar association between these ...
Cardiovascular health and the modifiable burden of incident myocardial infarction: The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-03-06)
Background: The American Heart Association has proposed an impact goal for the year 2020 to improve
cardiovascular health by 20%. The objectives of the study were to assess the association between the proposed
cardiovascular health metric score and incident myocardial infarction (MI) and to estimate the generalized impact
fraction (GIF).
<p>Methods: The health metric score was derived from ideal ...
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Genetic variations in the Vitamin D receptor predict type 2 diabetes and myocardial infarction in a community-based population: The tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2015-12-23)
Background
Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and
health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and
mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This
may be related to genetic differences. Thus, rs7968585, a single nucleotide polymorphism
(SNP) of the vitamin D receptor ...
Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-02-16)
Background:<br>Vitamin D deficiency may be a risk factor for mortality but previous meta-analyses lacked standardization of laboratory methods for 25-hydroxyvitamin D (25[OH]D) concentrations and used aggregate data instead of individual participant data (IPD). We therefore performed an IPD meta-analysis on the association between standardized serum 25(OH)D and mortality.<br>Methods:<br>In a European ...
Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-05-10)
Background: Recent studies have demonstrated an association between venous thromboembolism (VTE) and arterial thrombotic diseases.
<p> Objectives: We aimed to study the association between incident myocardial infarction (MI) and VTE in a prospective population-based cohort.
<p> Methods: Study participants (n=29 506) were recruited from three surveys of the Tromsø Study (conducted in 1994-95, 2001-02 ...
Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-08-21)
Objectives: <br> Elevated blood cholesterol is a modifiable
risk factor for cardiovascular disease. Cholesterol level
surveillance is necessary to study population disease
burden, consider priorities for prevention and intervention
and understand the effect of diet, lifestyle and treatment.
Previous studies show a cholesterol decline in recent
decades but lack data to follow individuals born ...